Literature DB >> 34314620

Use of Scrambler Therapy in the Treatment of Amyloidosis Neuropathic Pain.

Joann B Hunsberger1,2, Vaishali Rathee2, Thomas J Smith3.   

Abstract

Background: Scrambler therapy (ST) is a relatively new neuromodulation technique that is useful in treatment of medication-resistant pain syndromes, including chemotherapy-induced peripheral neuropathy and other chronic pain syndromes. Amyloidosis commonly leads to peripheral neuropathy, and although the mechanism is unclear, it is possibly related to amyloid deposits on the nerve. Case Presentation: In this case presentation, we describe the novel use of ST for a patient with 13 years of neuropathic pain related to amyloidosis and worsened by chemotherapy. The patient reported bilateral hand pain with burning and aching and bilateral numbness on the soles of her feet. Her upper extremities were treated with 4 days of 40 minute ST treatment sessions providing reduction in her pain scores to zero. Discussion: Current therapy for amyloid peripheral neuropathy aims at treating the underlying condition, and then medical management with gabapentinoids. This is first case presentation showing successful treatment with ST.

Entities:  

Keywords:  amyloidosis; neuromodulation; neuropathic pain; scrambler therapy

Mesh:

Year:  2021        PMID: 34314620      PMCID: PMC8568780          DOI: 10.1089/jpm.2020.0786

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  12 in total

Review 1.  Peripheral Nervous System Involvement.

Authors:  Pariwat Thaisetthawatkul; P James B Dyck
Journal:  Hematol Oncol Clin North Am       Date:  2020-09-10       Impact factor: 3.722

2.  Scrambler therapy for chemotherapy neuropathy: a randomized phase II pilot trial.

Authors:  Charles Loprinzi; Jennifer G Le-Rademacher; Neil Majithia; Ryan P McMurray; Carrie R O'Neill; Markus A Bendel; Andreas Beutler; Daniel H Lachance; Andrea Cheville; David M Strick; David F Black; Jon C Tilburt; Thomas J Smith
Journal:  Support Care Cancer       Date:  2019-06-17       Impact factor: 3.603

3.  Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial.

Authors:  Giuseppe Marineo; Vittorio Iorno; Cristiano Gandini; Vincenzo Moschini; Thomas J Smith
Journal:  J Pain Symptom Manage       Date:  2011-07-16       Impact factor: 3.612

Review 4.  Neuropathy Associated with Systemic Amyloidosis.

Authors:  Michelle Kaku; John L Berk
Journal:  Semin Neurol       Date:  2019-10-22       Impact factor: 3.420

5.  Scrambler therapy improves pain in neuromyelitis optica: A randomized controlled trial.

Authors:  Maureen A Mealy; Sharon L Kozachik; Lawrence J Cook; Lauren Totonis; Ruth Andrea Salazar; Jerilyn K Allen; Marie T Nolan; Thomas J Smith; Michael Levy
Journal:  Neurology       Date:  2020-04-08       Impact factor: 9.910

6.  The Efficacy of Scrambler Therapy for the Management of Head, Neck and Thoracic Cancer Pain: A Randomized Controlled Trial.

Authors:  Komal Kashyap; Vishwajeet Singh; Seema Mishra; Sada Nand Dwivedi; Sushma Bhatnagar
Journal:  Pain Physician       Date:  2020-09       Impact factor: 4.965

7.  Treatment of Déjerine-Roussy syndrome pain with scrambler therapy.

Authors:  Paul J Christo; David O Kamson; Thomas J Smith
Journal:  Pain Manag       Date:  2020-05-12

8.  A Pilot Randomized Sham-Controlled Trial of MC5-A Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN).

Authors:  Thomas J Smith; A Rab Razzak; Amanda L Blackford; Jennifer Ensminger; Catherine Saiki; Denise Longo-Schoberlein; Charles L Loprinzi
Journal:  J Palliat Care       Date:  2019-02-03       Impact factor: 2.250

Review 9.  Inside the Scrambler Therapy, a Noninvasive Treatment of Chronic Neuropathic and Cancer Pain: From the Gate Control Theory to the Active Principle of Information.

Authors:  Giuseppe Marineo
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

10.  Randomized Trial of Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy: Crossover Analysis.

Authors:  Daniel S Childs; Jennifer G Le-Rademacher; Ryan McMurray; Markus Bendel; Carrie O'Neill; Thomas J Smith; Charles L Loprinzi
Journal:  J Pain Symptom Manage       Date:  2020-11-27       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.